Comparative cardiovascular effects of GLP-1 agonists using real-world data.

Amisha WalliaMatthew O'BrienStephanie HakimianRaymond KangAndrew CooperNicola LanckiJohn J StephenCassandra AikmanDavid LissEmily ParkerRonald T Ackermann

Published in: Endocrinology, diabetes & metabolism (2023)

Initiating either immediate or extended-release exenatide rather than liraglutide was not associated with significant differences in CVD risk in this observational real-world study.

Keyphrases

big data
cross sectional
machine learning
data analysis
artificial intelligence